Atlanta Ride-Hail Drivers Rally for Unionization, Seek Fair Pay and Job Security
Atlanta ride-hail drivers are mobilizing to form a union, protesting for better pay and working conditions, highlighting systemic issues such as pay disparities and potential racial discrimination in platform deactivations.
University of Georgia's Intranasal COVID-19 Vaccine CVXGA Set for Clinical Trials in Fall
The University of Georgia's intranasal COVID-19 vaccine, CVXGA, is set for clinical trials with 10,000 participants to compare its effectiveness to current mRNA vaccines. Developed by UGA start-up CyanVac, it uses a modified parainfluenza virus.
Clayton County Offers Advanced Excel Training to Sharpen Data Management Skills
Clayton County is offering an advanced Microsoft Excel II training course for individuals with basic knowledge, covering complex functions and shortcuts; registration is required and hands-on participation is encouraged.
Atlanta Pediatric Power Players Turbocharge High-Tech Care For Kids
Three Atlanta leaders were named Innovators of the Year for pediatric health, recognized for work spanning clinical care, community programs and high‑tech research partnerships. One honoree helped drive the move of a $153M Shriners research institute to Science Square.
Supreme Court Lets Atlanta’s Cox Off The Hook In Billion-Dollar Piracy Brawl
The Supreme Court ruled that Cox Communications cannot be held liable for customers’ music downloads, overturning a jury award that once topped $1 billion. The decision reshapes how ISPs may be held responsible for users’ copyright violations.
Atlanta Tech Boomtown: City’s 2025 Impact Report Bets Big on Jobs and Data Centers
A new 2025 report from the mayor’s tech team highlights fresh job growth and investment in Atlanta’s tech sector, pointing to data‑center builds and research projects. City officials say training pipelines will be next.
Boston Scientific Makes $1.5 Billion Power Play on MiRus Heart Valve
Boston Scientific paid $1.5 billion for a roughly 34% stake in MiRus and an option to acquire the SIEGEL TAVR business, a potential fast path back into balloon‑expandable valves. The move hinges on clinical and regulatory milestones.








-3.webp?max-h=350&w=550&fit=crop)
















